Literature DB >> 28149905

Polytherapy as first-line in status epilepticus: should we change our practice? "Time is brain"!

Ashalatha Radhakrishnan1.   

Abstract

Entities:  

Year:  2016        PMID： 28149905      PMCID： PMC5233510          DOI： 10.21037/atm.2016.11.37

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  24 in total

1.  Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.

Authors:  Vincent Alvarez; Jong Woo Lee; Frank W Drislane; M Brandon Westover; Jan Novy; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Epilepsia       Date:  2015-07-03       Impact factor: 5.864

2.  The established status epilepticus trial 2013.

Authors:  Thomas Bleck; Hannah Cock; James Chamberlain; James Cloyd; Jason Connor; Jordan Elm; Nathan Fountain; Elizabeth Jones; Daniel Lowenstein; Shlomo Shinnar; Robert Silbergleit; David Treiman; Eugen Trinka; Jaideep Kapur
Journal:  Epilepsia       Date:  2013-09       Impact factor: 5.864

3.  Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.

Authors:  Vincent Navarro; Christelle Dagron; Caroline Elie; Lionel Lamhaut; Sophie Demeret; Saïk Urien; Kim An; Francis Bolgert; Jean-Marc Tréluyer; Michel Baulac; Pierre Carli
Journal:  Lancet Neurol       Date:  2015-11-28       Impact factor: 44.182

4.  Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study.

Authors:  U K Misra; J Kalita; P K Maurya
Journal:  J Neurol       Date:  2011-09-06       Impact factor: 4.849

5.  Status epilepticus at an urban public hospital in the 1980s.

Authors:  D H Lowenstein; B K Alldredge
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

6.  In-hospital mortality of generalized convulsive status epilepticus: a large US sample.

Authors:  Mohamad Koubeissi; Amer Alshekhlee
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

7.  Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy.

Authors:  Henrik Klitgaard; Alain Matagne; Renee Grimee; Jocelyne Vanneste-Goemaere; Doru-Georg Margineanu
Journal:  Seizure       Date:  2003-03       Impact factor: 3.184

8.  Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.

Authors:  C Kellinghaus; S Berning; F Stögbauer
Journal:  Acta Neurol Scand       Date:  2013-08-13       Impact factor: 3.209

9.  Comparison of Antiepileptic Approaches in Treatment of Benzodiazepine Nonresponsive Status Epilepticus.

Authors:  Armin Bachhuber; Maike Lasrich; Ramona Halmer; Klaus Fassbender; Silke Walter
Journal:  CNS Neurosci Ther       Date:  2016-02-04       Impact factor: 5.243

Review 10.  Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.

Authors:  Eugen Trinka; Julia Höfler; Alexander Zerbs; Francesco Brigo
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749
View more
  2 in total

1.  Open-label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures.

Authors:  Giulia Cagnotti; Rosangela Odore; Iride Bertone; Cristiano Corona; Elena Dappiano; Giulia Gardini; Barbara Iulini; Claudio Bellino; Antonio D'Angelo
Journal:  J Vet Intern Med       Date:  2019-06-20       Impact factor: 3.333

Review 2.  Pharmacotherapy for Pediatric Convulsive Status Epilepticus.

Authors:  Avantika Singh; Coral M Stredny; Tobias Loddenkemper
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.